Q3 2015 Holdings
Filed 2015-11-04 | 10 holdings | $177.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Juno Therapeutics | Common Stock | 48205A109 | $54.1K | 1,329,512 | 30.5% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $40.6K | 2,138,872 | 22.9% |
| Egalet | Common Stock | 28226B104 | $34.9K | 2,645,558 | 19.6% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $19.1K | 872,175 | 10.8% |
| Nabriva Therapeutics | Sponsored ADR | 62957M104 | $10.9K | 1,145,890 | 6.1% |
| Essa Pharma | Common Stock | 29668H104 | $6.9K | 1,090,909 | 3.9% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $4.5K | 2,483,949 | 2.6% |
| Proteon Therapeutics | Common Stock | 74371L109 | $3.5K | 250,000 | 2.0% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $1.8K | 223,457 | 1.0% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $1.3K | 650,000 | 0.7% |